University of Naples "Federico II"
Naples, 80100, Italy
NCT Number: NCT04491773
This study evaluates the retinal and choriocapillary vascular features in patients under the effects of Tadalafil 20mg for more than 6 months, using optical coherence tomography angiography.
Looking for future studies?
Notify Me45 year–70 year
Male
Observational
Naples, 80100, Italy
Tadalafil is a an inhibitor of the enzyme phosphodiesterase and it works by increasing blood flow to the penis thus promoting the erection.
This drug represents an treatment for erectile dysfunction in patients after radical prostatectomy.
The optical coherence tomography angiography represents a novel and noninvasive diagnostic technique that allows a detailed and quantitative analysis of retinal and choriocapillary vascular features.
The study evaluates the changes in optical coherence tomography angiography features after the somministration of Tadalafil 20 mg orally for more than 6 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
To study retinal and choriocapillary features in patients undergoing Tadalafil 20 mg orally, on alternate days, for more than 6 months.
Other names: Cialis
Time frame: More than 6 months
Changes in retinal and choriocapillary vessel density in patients after radical prostatectomy, undergoing Tadalafil 20 mg orally on alternate days for more than 6 months, using optical coherence tomography angiography.
The parameters analyzed by optical coherence tomography angiography were: retinal and choriocapillary vessel density
Federico II University
Other
Evaluation of Retinal and Choriocapillary Vascular Changes Using Optical Coherence Tomography Angiography in Patients Undergoing Tadalafil 20mg on Alternative Days for More Than 6 Months: a Single-centre Prospective-control
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05673005
Erectile Dysfunction Following Radical Prostatectomy
Boston, Massachusetts, United States
View Trial DetailsNCT05332340
Erectile Dysfunction, Erectile Dysfunction Following Radical Prostatectomy
Valinhos, São Paulo, Brazil
View Trial DetailsNCT06743048
Erectile Dysfunction, Erectile Dysfunction Associated With Type 2 Diabetes Mellitus
Cairo, Egypt
View Trial DetailsNCT05772598
Erectile Dysfunction Following Radical Prostatectomy, Genital Diseases
London, United Kingdom
View Trial Details